SCHEMBL1976091

SCHEMBL1976091

C=[C]I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL639752 0.61
SCHEMBL155684 0.58
Ammonia Solution, Strong SCHEMBL11413772 0.55
Ammonia Solution, Strong SCHEMBL6518320 0.55
Hydrogen Sulfide SCHEMBL11679956 0.55
Water SCHEMBL277569 0.55
SCHEMBL4515236 0.55
SCHEMBL144636 0.55
SCHEMBL1056772 0.55
Ethylene SCHEMBL7180381 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024039743-A1 COMPOSITIONS AND METHODS FOR SELECTIVE LABELING OF PRIMARY AMIDES WITH IODOVINYL COMPOUNDS EMORY UNIVERSITY (US) 2024-02-22 WO claimed
EP-1239886-B1 LABELLED ASCORBIC ACID DERIVATIVES GE HEALTHCARE LTD (GB) 2006-11-29 EP claimed
US-6749832-B2 DIAGNOSIS, PROGNOSIS AND RADIOTHERAPY OF METASTATIC BONE DISEASE; SUCH AS TAGGED 5-(2-AMINO-1-HYDROXYETHYL)-3,4-DIBENZYLOXY-5H-FURAN-2-ONE AMERSHAM PLC (GB) 2004-06-15 US claimed
US-20030153736-A1 Labelled ascorbic acid derivatives GE HEALTHCARE LIMITED (GB) 2003-08-14 US claimed
EP-0365421-B1 Specific ligands for estrogenic and progestagenic steroidal hormone receptors, their use and synthesis intermediates WALLONE REGION (BE) 1994-03-23 EP claimed
EP-0310645-B1 COMPOUNDS USEFUL PARTICULARLY FOR RADIOTHERAPY OR IMAGING OF CANCER IRE-CELLTARG S.A. (BE) 1992-06-10 EP claimed
US-5006518-A Hormone inhibitors for inducing abortions; nontoxic ROUSSEL UCLAF (FR) 1991-04-09 US claimed
EP-0234494-B1 ISOHEXIDE NUCLEOSIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS Heinrich Mack Nachf. (DE) 1991-03-13 EP claimed
EP-0365421-A1 Specific ligands for estrogenic and progestagenic steroidal hormone receptors, their use and synthesis intermediates LA REGION WALLONNE (BE) 1990-04-25 EP claimed
EP-0169515-B1 17-HALOVINYL ESTRANE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN MEDICINES SCHERING AKTIENGESELLSCHAFT (DE) 1989-10-11 EP claimed
EP-0310645-A1 COMPOUNDS USEFUL PARTICULARLY FOR RADIOTHERAPY OR IMAGING OF CANCER. IRECELLTARG S A (BE) 1989-04-12 EP claimed
US-4806542-A VIRISTATICS, IMMUNOSTIMULANTS HEINRICH MACK NACHF. (DE) 1989-02-21 US claimed
WO-1988007986-A2 COMPOUNDS USEFUL PARTICULARLY FOR RADIOTHERAPY OR IMAGING OF CANCER IRE-CELLTARG S.A. (BE) 1988-10-20 WO claimed
EP-0234494-A2 Isohexide nucleosides, processes for their preparation and their use as medicaments Heinrich Mack Nachf. (DE) 1987-09-02 EP claimed
JP-1213296-A None JP disclosed
WO-2024039743-A1 COMPOSITIONS AND METHODS FOR SELECTIVE LABELING OF PRIMARY AMIDES WITH IODOVINYL COMPOUNDS EMORY UNIVERSITY (US) 2024-02-22 WO disclosed
WO-2024039743-A1 COMPOSITIONS AND METHODS FOR SELECTIVE LABELING OF PRIMARY AMIDES WITH IODOVINYL COMPOUNDS EMORY UNIVERSITY (US) 2024-02-22 WO disclosed
US-4005993-A CYCLOPENTADIENYL MANGANESE TRICARBONYL, OXYALKYL-MALONIC ACIDS OR ESTERS ETHYL CORPORATION (US) 1977-02-01 US disclosed
US-3958955-A CYCLOPENTADIENYL MANGANESE TRICARBONYL ANTIKNOCK ETHYL CORPORATION (US) 1976-05-25 US disclosed
US-3950145-A ANTIKNOCK ETHYL CORPORATION (US) 1976-04-13 US disclosed